Good morning. Welcome to the Traws Pharma 2026 Annual Meeting of Stockholders. I would now like to turn the meeting over to Jack Stover, the Chairman of the Board of Traws Pharma. Thank you, operator. Good morning, ladies and gentlemen. Will the meeting please come to order? I want to welcome all of you to the 2026 Annual Meeting of Stockholders of Traws Pharma, Inc. As you are aware, we have adopted a virtual format for our meeting. I will be presiding at this meeting with Dr. Iain Dukes, CEO of Traws Pharma. Charles Parker, Traws Pharma's CFO, will act as Secretary of the meeting. Jim Rate, representing Broadridge, has been appointed to act as Inspector of Election. We are joined today by other members of our Board of Directors and officers of Traws Pharma, Inc. Shareholders, as of the record date, may attend the annual meeting by logging in with the control number provided on their proxy card, voting instruction form, or notice of internet availability of proxy materials. If you are not a shareholder, do not have a control number, you may still access the meeting as a guest, you will not be able to participate. Shareholders entitled to vote at the annual meeting may vote during the meeting using the link at the bottom of the screen. Shareholders may also ask questions during the meeting using the question text box at the bottom of the screen. Questions pertaining to the proposals to be voted on will be answered before the voting is closed. Other questions will be answered at the end of the meeting. The close of business on May 18th, 2026, has been fixed as the record date for the determination of shareholders entitled to receive notice of and to vote at the annual meeting. As of the close of business on such date, we had outstanding entitled to vote 15,150,669 shares of our common stock. On or about May 29th, 2026, Traws mailed its notice regarding availability of proxy materials for the annual meeting to all shareholders of record as of May 18th. The Secretary was given an affidavit of mailing provided by Broadridge, establishing that notice of this meeting was duly given and a proxy statement and a form of proxy was sent to each shareholder of record. A copy of the notice of meeting and the affidavit of meeting will be incorporated into the minutes of this meeting. Our first order of business at this meeting is to determine whether the shares represented at the meeting, either in person or by proxy, are sufficient to constitute a quorum for the purpose of transacting business. Charles, do you have a report? Yes. We're informed by the Inspector of Election that there are represented in person or by proxy, approximately 8.5 million shares of common stock, or approximately 56% of all the shares entitled to vote at this meeting. Because this represents more than 1/3 of the shares entitled to vote at this meeting, a quorum is present, and the meeting may continue for the transaction of business. The shareholders list is available if any shareholder wishes to examine it and will be filed with the minutes of the annual meeting. Jack? Thank you. I now declare this meeting to be duly convened for purposes of transacting such business as may be properly come before it. The polls are now open. If there are any shareholders who haven't yet voted or wish to change their vote, they may do so before closing of the polls by using the link at the bottom of the screen. Shareholders who have sent in proxies or voted via telephone or internet and do not want to change their vote do not need to take any further action. After the polls are closed, we will release preliminary results of the votes. I will now hand it to Iain to review the proposals being voted upon. Thank you, Jack. The next order of business is a description of the proposals to be voted on at today's meeting. Proposal number 1, election of directors. The first proposal is to approve the election of seven directors to serve until the next Annual Meeting of Shareholders and until his or her successor is duly elected and qualified, subject to such director's prior death, resignation, retirement, disqualification, or other removal. Proposal number 2. [audio distortion] Jack, I'll continue to go through the proposals. Please. Proposal number 2, amendment to the company's 2021 Incentive Compensation Plan, as amended and restated. The second proposal is to increase the number of shares of common stock available for issuance by 2 million and make certain other administrative changes. Proposal number 3, ratification of the selection of independent registered public accounting firm. The third proposal is to ratify the selection of KPMG LLP as the company's independent registered public accounting firm for fiscal year 2026. We provided you with information regarding our independent registered accounting firm and the services it provides in the proxy statement. Proposal number 4, issuance of shares of our common stock upon exercise of those Series B warrants and Series C warrants. The fourth proposal is to approve the issuance of shares of our common stock upon exercise of those Series B warrants and Series C warrants pursuant to that certain securities purchase agreement entered into by and between us and such investors on April 15, 2026. Proposal number 5, authorization of an adjournment of the annual meeting. The fifth proposal is to authorize the adjournment of the annual meeting to another place or a later date or dates. At this point, I'll hand it back over to Jack, who will address any questions and walk through the current voting results. Thank you. We will now answer any questions pertaining to the proposals. Other questions will be answered at the end of the meeting. Charles, do we have any questions pertaining to the proposals? Jack, we have not received any questions pertaining to the proposals. Thank you, Charles. No other matters have been properly brought before the meeting. The polls are still open with respect to all of the proposals. Should any shareholder desire to vote now, please click on the voting button at the bottom of the screen and follow the instructions provided. If you have already submitted your proxy and you do not wish to change your voting instructions, you need not take any further action. We will now take a few minutes to provide the stockholders with the opportunity to submit or change their votes before closing the polls and announcing the preliminary voting results. The polls for each matter to be voted on at this meeting are now closed. The Inspector of Election will count the votes on the proposals. The Inspector of Election will now report the preliminary results of the voting. The final results will be filed with the SEC on a Form 8-K within four business days of this meeting. Thank you, Mr. Chairman. For Proposal 1, each of the director nominees has been elected. On Proposal 2, the amendment to the company's 2021 Incentive Compensation Plan, as amended and restated, has been approved. On Proposal 3, the ratification of KPMG LLP as the company's independent registered public accounting firm has been approved. On Proposal 4, the issuance of the shares of common stock upon exercise of certain Series B and Series C warrants has been approved. Finally, on Proposal 5, the adjournment of the annual meeting has been approved. However, because of all the other proposals have been approved, I've been advised by Dr. Dukes that the meeting will not be adjourned to a later date or time. I will prepare the final report as soon as practical and deliver to the Secretary of the meeting to be filed with the minutes of the annual meeting. Back over to you, Mr. Chairman. All the proposals have been approved. There being no further business to come before the meeting, the Traws 2026 Annual Meeting of Shareholders is now adjourned. With the formal part of the meeting now over, we will answer shareholder questions. Charles, have we received any questions? No, Jack, we have not received any questions. Since there are no further questions today, I want to thank each of you for joining us today for the Traws Pharma 2026 annual meeting and for the interest you have shown in the affairs of the company. Again, thank you for attending today's meeting. That concludes our meeting today. You may now disconnect.